NCT04472767

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2020-08-07Est. Completion: 2027-01-31

Enrollment target: 35 participants

Locations

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

Contact

Chao Family Comprehensive Cancer Center University of California, Irvineucstudy@uci.edu 1-877-827-7883

University of California Irvine Medical

Hepatocellular Carcinoma (HCC)

This study evaluates whether Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) improves ov…

Toronto, CanadaEst. completion Dec 1, 2031

Hepatocellular Carcinoma Non-Resectable

Each year, approximately 1,000 patients in the Netherlands are diagnosed with liver cancer. When liver cancer can no lon…

Nijmegen, NetherlandsEst. completion Sep 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.